Basiliximab Approval Information - Licensing Action

Proper name: Basiliximab
Tradename: Simulect
Manufacturer: Novartis Pharmaceutical Corp, East Hanover, NJ, License #1244
Indication for Use: Include the addition of a new single dose 10mg strength of drug product
Approval Date: 1/2/2003
Type of submission: Biologics license application supplement


Label (PDF)

Page Last Updated: 05/13/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.